Cancer is one of the leading causes of death in the U.S., and is expected to be the number one killer in 16 years. Men are more likely to die of cancer than women, but scientific advancements like antibiotics, vaccines, and chemotherapy have decreased how often people die of cancer. Prostate cancer is the leading cancer for males, but there are other cancers men should protect themselves against as well. Prostate cancer is the number one cancer risk for men, and the number two cancer killer (after lung cancer). About one man in seven will be diagnosed with prostate cancer during his lifetime, according to the American Cancer Society.
Cancer deaths among women are expected to climb 60 percent by 2030, due to an uptick in breast and cervical cancer cases, according to a series of reports published Tuesday. The number of women killed by breast cancer could nearly double to 3.2 million by 2030, said one of three reports published in the Lancet medical journal. Cervical cancer diagnoses are expected to increase 25 percent in the same time frame. "We have not been paying attention to the burden of cancer in terms of women's health. It's really much higher than we had thought it was," Sally Cowal, senior VP of global health at ACS, told PBS NewsHour.
A drug currently used to treat ovarian cancer could help in treating one of the most aggressive forms of breast cancer. A team of Irish researchers found the drug APR-246 prevents the growth of triple-negative breast cancer cells. The study, published in the International Journal of Cancer, concludes that if the drug is successful in clinical trials, it could potentially save the lives of patients diagnosed with triple-negative breast cancer, which is very difficult to treat. "At the moment the only form of drug treatment available to patients with triple negative breast cancer is chemotherapy," the study's co-author Naoise Synnott, a Ph.D. student at University College Dublin (UCD), reportedly said. "While this will work well for some patients, others may find that their cancer cells don't respond as well as might be hoped to chemo, leading patients suffering the side effects of this treatment without any of the desired outcomes."
Taking statins could help thousands of women avoid breast cancer returning after surgery, scientists have found. British researchers discovered that cholesterol can hamper the way common breast cancer drugs work, helping tumours become resistant to treatment. The breakthrough – described as a'crucial discovery' – suggests that taking cheap and readily available statins alongside cancer drugs could significantly increase survival rates. More than 53,000 women are diagnosed with breast cancer in Britain each year. About 80 per cent of these suffer with a form that is driven by the female hormone oestrogen, called ER-positive breast cancer.
A record 1.01 million people are expected to be diagnosed with cancer this year, the first time the figure has topped the 1 million mark, the National Cancer Center said Friday. NCC put the number of cancer deaths forecast this year at 374,000, also a record high. The center cites an aging population as the biggest reason for the rise in expected cancer incidences and deaths, a consistent trend since the 1970s when officials started to record statistics. The 1.01 million cases would mark an increase of 28,000 compared to last year. By gender, men are seen as slightly more vulnerable to cancer.